retatrutide phase 2 obesity nejm 2023 jastreboff Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial retatrutide phase 2 nejm 2023
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5




























